Symbol="ALPN"
AssetType="Common Stock"
Name="Alpine Immune Sciences Inc"
Description="Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune / inflammatory disorders, and other diseases. The company is headquartered in Seattle, Washington."
CIK="1626199"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="650875000"
EBITDA="-64873000"
PERatio="None"
PEGRatio="0"
BookValue="3.448"
DividendPerShare="0"
DividendYield="0"
EPS="-1.42"
RevenuePerShareTTM="0.69"
ProfitMargin="-2.011"
OperatingMarginTTM="-2.247"
ReturnOnAssetsTTM="-0.175"
ReturnOnEquityTTM="-0.435"
RevenueTTM="29123000"
GrossProfitTTM="-40179000"
DilutedEPSTTM="-1.42"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.624"
AnalystTargetPrice="16.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.42"
PriceToBookRatio="1.524"
EVToRevenue="1.385"
EVToEBITDA="-0.857"
Beta="1.252"
num_52WeekHigh="14.92"
num_52WeekLow="4.82"
num_50DayMovingAverage="11.93"
num_200DayMovingAverage="8.75"
SharesOutstanding="49201500"
DividendDate="2017-07-25"
ExDividendDate="None"
symbol="ALPN"
open="12.97"
high="13.22"
low="12.74"
price="13.15"
volume="142282.00"
latest_trading_day="2023-08-25"
previous_close="12.88"
change="0.27"
change_percent="2.0963%"
aroon_positive_momentum_days="72"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="72"
Volume_recent_avg="182480"
Change_recent_avg="0.03"
Delta_recent_avg="0.56"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="72"
Aroon_momentum_negative="28"
image_negative_thumbnail_id_1="92"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_negative_thumbnail_id_2="520"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0085.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="535"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_positive_thumbnail_id_1="971"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0133.jpeg"
image_positive_thumbnail_id_2="695"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
